Brief Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 7, 2011; 17(45): 4987-4992
Published online Dec 7, 2011. doi: 10.3748/wjg.v17.i45.4987
Table 3 Rates of tyrosine-methionine-aspartate-aspartate mutation in patients with chronic hepatitis B virus infection n (%)
Chronic hepatitis BInactive HBsAg carriersTotal
Previous lamivudine treatment
Total
Yes1
No
YVDD + YIDD positive17 (53.1)8 (4)25 (10.7)1 (3)26 (9.7)
YMDD negative15 (46.9)194 (96)209 (89.3)32 (97) 241 (90.3)
Total3220223433267